[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-RYTM":3,"homepage-market-summary":31,"stock-news-RYTM":175},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"RYTM","2026-10-08",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Rhythm Pharmaceuticals, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.","414","Boston, MA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},89.64,89.05,90.94,87.01,88.45,1.19,1.35,943822.035732,18834,89.2614,122.2,74.5,760931.586730251,31.7,2262,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":154},"success",[34,41,48,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":14,"sparkline":40,"date":5},"SPX","S&P 500",7765.36,-36.41,-0.47,"0.0,10.5 2.3,12.4 4.6,14.2 6.9,16.0 9.3,11.5 11.6,10.8 13.9,4.8 16.2,4.8 18.5,7.9 20.8,8.0 23.2,6.0 25.5,9.1 27.8,9.8 30.1,10.8 32.4,10.0 34.7,7.0 37.1,4.4 39.4,2.0 41.7,2.9 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":14,"sparkline":47,"date":5},"NDX","NASDAQ 100",30725.81,-434.27,-1.39,"0.0,13.4 2.3,14.8 4.6,16.0 6.9,16.0 9.3,12.9 11.6,11.7 13.9,6.5 16.2,5.0 18.5,6.6 20.8,6.6 23.2,5.8 25.5,7.8 27.8,7.4 30.1,7.0 32.4,6.4 34.7,4.6 37.1,2.9 39.4,2.0 41.7,2.4 44.0,5.1",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":54,"sparkline":55,"date":5},"DJI","DOW JONES",51232,52,0.1,true,"0.0,2.0 2.3,3.3 4.6,6.0 6.9,11.3 9.3,8.7 11.6,9.5 13.9,6.4 16.2,8.0 18.5,10.9 20.8,12.3 23.2,8.2 25.5,11.2 27.8,12.3 30.1,16.0 32.4,15.8 34.7,13.7 37.1,13.0 39.4,10.8 41.7,13.7 44.0,13.3",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":14,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27193.34,-345.35,-1.25,"0.0,12.9 2.3,14.2 4.6,16.0 6.9,16.0 9.3,12.2 11.6,11.3 13.9,6.1 16.2,5.1 18.5,7.7 20.8,7.7 23.2,6.6 25.5,8.7 27.8,8.9 30.1,8.4 32.4,8.3 34.7,5.5 37.1,3.1 39.4,2.0 41.7,2.5 44.0,5.5",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":14,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2775.7,-1.3,-0.05,"0.0,2.0 2.3,4.1 4.6,6.6 6.9,8.1 9.3,6.3 11.6,7.9 13.9,6.1 16.2,4.1 18.5,10.6 20.8,10.9 23.2,10.6 25.5,13.0 27.8,14.2 30.1,15.6 32.4,14.2 34.7,11.1 37.1,8.8 39.4,11.3 41.7,15.8 44.0,16.0",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":54,"sparkline":76,"date":5},"VIX","CBOE VIX",15.41,0.33,2.19,"0.0,9.5 2.3,4.4 4.6,4.0 6.9,2.0 9.3,11.1 11.6,13.6 13.9,13.4 16.2,16.0 18.5,12.1 20.8,10.2 23.2,13.4 25.5,8.6 27.8,8.7 30.1,7.5 32.4,7.3 34.7,11.6 37.1,10.8 39.4,12.8 41.7,12.5 44.0,11.2",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":14,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",230.48,-6.99,-2.94,"0.0,16.0 7.3,12.8 14.7,8.8 22.0,2.4 29.3,2.0 36.7,4.3 44.0,13.3",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":54,"sparkline":91,"date":5},"AAPL","Apple Inc",340.43,3.76,1.12,"0.0,12.3 7.3,16.0 14.7,11.3 22.0,12.4 29.3,11.4 36.7,7.2 44.0,2.0",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":14,"sparkline":98,"date":5},"TSLA","Tesla Inc",375,-2.81,-0.74,"0.0,15.6 7.3,16.0 14.7,7.3 22.0,3.0 29.3,2.0 36.7,3.5 44.0,5.0",[100,105,110,115,120,125,130,134,139,144,149],{"name":101,"etf":102,"change":103,"price":104,"is_up":14},"Technology","XLK",-1.79,197.78,{"name":106,"etf":107,"change":108,"price":109,"is_up":54},"Financials","XLF",0.89,54.23,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.39,168.16,{"name":116,"etf":117,"change":118,"price":119,"is_up":54},"Consumer Cycl","XLY",0.31,111.7,{"name":121,"etf":122,"change":123,"price":124,"is_up":54},"Consumer Staples","XLP",2.11,83.42,{"name":126,"etf":127,"change":128,"price":129,"is_up":54},"Energy","XLE",2.97,65.24,{"name":131,"etf":132,"change":74,"price":133,"is_up":54},"Industrials","XLI",168.4,{"name":135,"etf":136,"change":137,"price":138,"is_up":54},"Materials","XLB",0.59,49.27,{"name":140,"etf":141,"change":142,"price":143,"is_up":54},"Real Estate","XLRE",0.69,40.85,{"name":145,"etf":146,"change":147,"price":148,"is_up":14},"Utilities","XLU",-0.19,41.07,{"name":150,"etf":151,"change":152,"price":153,"is_up":54},"Comm Services","XLC",0.73,112.07,[155,160,165,170],{"ticker":156,"name":157,"price":158,"change":159,"is_up":14},"SPY","SPDR S&P 500 ETF",773.97,-0.42,{"ticker":161,"name":162,"price":163,"change":164,"is_up":14},"QQQ","Invesco QQQ Trust",747.58,-1.34,{"ticker":166,"name":167,"price":168,"change":169,"is_up":54},"DIA","SPDR Dow Jones ETF",511.65,0.12,{"ticker":171,"name":172,"price":173,"change":174,"is_up":14},"IWM","iShares Russell 2000",277.63,-0.03,{"ticker":4,"count":176,"articles":177},5,[178,184,190,196,202],{"title":179,"link":180,"pubDate":181,"description":182,"source":183},"Here’s How Much You Would Have Made Owning Rhythm Pharmaceuticals Stock In The Last 5 Years - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxNSzd4bVdacE1iVzVLbW51NnVTV2RXUkVDbXhDbGl1ckIzVFVnLUxNTjRBdjdacE9OMV9fNUUxSmxRcWR0X21sdHlrN3YtbTljaFcwMmgwZ0cwVi1tSEw0clM3RlR2NFFPcHBfcm1lR045cS1UX3puWF8tV1JRNjdSYTFPOS03ejJZY3FjbHVNb2JEdDlpdVUyczh3LU5sdkZZTThyaWc0Y1pqQVBMWE5BTVNmcjkwOVYwMUozOGZtOG9KY19oNDc0ZA?oc=5","Thu, 08 Oct 2026 14:45:18 GMT","Here’s How Much You Would Have Made Owning Rhythm Pharmaceuticals Stock In The Last 5 Years Benzinga","Benzinga",{"title":185,"link":186,"pubDate":187,"description":188,"source":189},"RYTM Maintained by RBC Capital -- Price Target Raised to $159 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinAFBVV95cUxQOXpYT29vQi1qNmhoZTF3VHJ2NVJKSTFJZmR2QTV3WVN6NVFvY2pDbkhHWGE4MFlzRzV4ZG55LUFvRkxTM0s1SFk0eHYtX212QUxSZGJuM280THRETjhoc0tGVVVxdnpQSWN5YmkxQnRiQ3ljdWRKYmVKR0t2VFJkQ1pLSHNWeUdtdVJoeTBVRzZqMlp3d2lreHJESWk?oc=5","Thu, 08 Oct 2026 15:58:36 GMT","RYTM Maintained by RBC Capital -- Price Target Raised to $159 GuruFocus","GuruFocus",{"title":191,"link":192,"pubDate":193,"description":194,"source":195},"Why (RYTM) Price Action Is Critical for Tactical Trading - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizwFBVV95cUxORnNOc2ZxRU9kWUhYMTJNQ2R6UW1GcnA2VEc0S3FsSFRjc1N6Z2xiM0RPdEhLQVZDWE5wNGE2Y3pvMW9sX2hMVWhpV0NYWGZxaXhCeVA3aWZBOUtSd2tuRy1haFlnMjZZUjlqVUxXOGM0RGJMRFRIY2V2ekEtNzRLb0F3R21leFdLYU9aQVF4T1pwZktTVGJRR21IRU5TYTZySmd3UUxlbkZ6Zk54UEUtNlZ4cjd3bGE3LW1HU3JXODViZExhMXhQYzFzbWRjTkk?oc=5","Sat, 03 Oct 2026 19:22:01 GMT","Why (RYTM) Price Action Is Critical for Tactical Trading Stock Traders Daily","Stock Traders Daily",{"title":197,"link":198,"pubDate":199,"description":200,"source":201},"RBC raises target for Rhythm Pharmaceuticals stock to USD 159 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxQV2pxd1NSVzZxbm0tVUZfVW1yc0NqOEZtZXlrUjRWN3lrcHg5ejAydHAwRXpReHd2SEJQdnRET3Y1WlB4b3doX0NPczBodE1KLTZUc3hfMmdkcVhfejN4U2FEVXBlNHppVXV0QTZxRk5veVYzQmpqX0s4Zmg5akViZlhtVmgzdm9pUnkwYTEtZnl4YmRuNmVXTFc0Y3ZSdkJES0FDWDV3b1ZzQW5SSmxUb2wtY0dQWHFxWWpUSA?oc=5","Thu, 08 Oct 2026 18:32:23 GMT","RBC raises target for Rhythm Pharmaceuticals stock to USD 159 AD HOC NEWS","AD HOC NEWS",{"title":203,"link":204,"pubDate":205,"description":206,"source":207},"RYTM Q2 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus, Shares Slip 2.89% - Revenue Recognition Risk - https:\u002F\u002Fwww.siam.in\u002F","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxQT3cyd1RPUDBWdjBVdFVrdlp4R2trWjV0ZDdiR3FVNVhxc1F6M2IwdHdET1lqMnNGdGpRS3VHTW9iREhHQ0h0RlR2bkRSWnV6MTVSZjlKVEVILUNtWlBRaXU5dU1WUmVzbnhxYlJSa0dNT1I3a21pOXoycVNQNTVFSFRzNVdHQzM4M0lQemdsRGRfRFJmQjc1ekVCOC1MUURaNUE2NWtiVlpZb0ZOWGFrc2dtaXhFbVlGb1Y4eEJEVQ?oc=5","Tue, 29 Sep 2026 23:35:31 GMT","RYTM Q2 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus, Shares Slip 2.89% - Revenue Recognition Risk https:\u002F\u002Fwww.siam.in\u002F","https:\u002F\u002Fwww.siam.in\u002F"]